WHAT ARE THE BENEFITS OF JEUVEAU INJECTABLE TREATMENTS?
Jeuveau received FDA approval in February 2019. It is less of a competitor to BOTOX than an alternative to it. Structurally, the two products are similar, and both offer the ability to temporarily improve the appearance of signs of aging such as frown lines and wrinkles in specific parts of the face. In general, botulinum toxin neuromodulator type A injections cosmetically treat wrinkles and provide a more youthful, overall smoother facial appearance.
BOTOX is FDA-approved to treat a longer list of medical concerns, whereas Jeuveau’s specific purpose is to address frown lines around and in between the eyebrows. Technically, the ingredients in the two products are about the same, but the manufacturing and purification processes differ. Jeuveau, for example, uses a proprietary Hi-Pure technology in its manufacturing process to separate itself from competing injectables.
While the similar nature of these injectables results in relatively the same benefits for the patient, sometimes one brand may work better than the other for you. If you’re already using BOTOX and it’s effective for you, there may be no reason to switch. However, if BOTOX (or Dysport or Xeomin) haven’t been working well for you, it may be time to give Jeuveau a trial in your anti-aging plan.
Various factors affect the overall cost of a treatment plan, but Jeuveau does seem to offer some price advantages at a lower cost per unit in most cases. It’s more accessible for a total rejuvenation or even touch-up treatments for some patients, but it usually just comes down to preference.